InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.38
(
0.13%
)
US TECH 100
17,632.00
(
0.12%
)
Dow Jones
38,960.30
(
0.28%
)
Brent Oil
82.65
(
-0.99%
)
Bitcoin
63,281.46
(
0.18%
)
Post# of 33
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

INFINITI

Send PM Follow Ignore
Followers 174
Posts 22524
Boards Moderated 0
Alias Born 11/01/2012

INFINITI

Re: None

Tuesday, 05/10/2022 10:20:24 AM

Tuesday, May 10, 2022 10:20:24 AM

Post# of 33
Therapeutics (LOGC) Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Logicbio Therapeutics yesterday and set a price target of $6.00. The company's shares closed last Monday at $0.67, close to its 52-week low of $0.39. According to TipRanks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!